NEW YORK ( TheStreet) -- Biosante Pharmaceuticals (Nasdaq: BPAX) is trading at unusually high volume Friday with 7.6 million shares changing hands. It is currently at four times its average daily volume and trading down 19 cents (-8.8%) at $1.96 as of 11:06 a.m. ET. Biosante has a market cap of $143.7 million and is part of the health care sector and drugs industry. Shares are up 31.1% year to date as of the close of trading on Thursday. BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, develops products for female sexual health and oncology. TheStreet Ratings rates Biosante as sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and generally weak debt management. You can view the full Biosante Ratings Report. See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.
More from Markets
Jim Cramer: A Cold War With China Is Worth Avoiding
I wish I could say buy this dip. But the dip is one that's not necessarily going to have an ending today.
China's New Tariffs on U.S. Stem From Domestic Political Calculus, Goldman Says
China's plan to impose new tariffs on U.S. imports might not be the best for the Asian country's economy, but it might be a politically savvy move from the standpoint of the country's leaders, Goldman Sachs says in a report.
Dow Utilities Hitting All-Time High Can Precede Recession -- But Not Always
The past several recessions have been preceded by all-time highs in utilities. But it's not a sure signal.